Please login to the form below

Not currently logged in
Email:
Password:

meningitis

This page shows the latest meningitis news and features for those working in and with pharma, biotech and healthcare.

Sanofi backs vaccines unit with €350m Canadian facility

Sanofi backs vaccines unit with €350m Canadian facility

vaccine Dengvaxia last year, as well as lumpy orders for its meningitis vaccine Menactra and overall static sales of paediatric combination shots.

Latest news

  • GSK's Shingrix sails through FDA advisory committee GSK's Shingrix sails through FDA advisory committee

    EvaluatePharma's latest World Preview report predicts that Shingrix will bring in worldwide product sales of $1.13bn in 2022, adding another blockbuster to GSK's vaccine portfolio alongside meningitis B

  • GSK makes case for revaccination with Shingrix GSK makes case for revaccination with Shingrix

    EvaluatePharma's latest World Preview report predicts that Shingrix will bring in worldwide product sales of $1.13bn in 2022, adding another blockbuster to GSK's vaccine portfolio alongside meningitis B

  • Pfizer wins EU approval for MenB vaccine Trumenba Pfizer wins EU approval for MenB vaccine Trumenba

    Pfizer's Trumenba has been approved for the prevention of meningitis B (MenB) in Europe, laying the ground for the first alternative to GlaxoSmithKline's Bexsero, supplies of which have been ... The UK-based Meningitis Research Foundation said it

  • GSK's Bexsero vaccine growing fast, despite GSK's Bexsero vaccine growing fast, despite "tight" supply

    GSK's Bexsero vaccine growing fast, despite "tight" supply. Meningitis drug’ s sales double as third quarter results exceed expectations. ... GlaxoSmithKline's meningitis vaccine Bexsero saw sales double in the third quarter, forcing the company to

  • Bexsero halved UK meningitis B cases in first year, says study Bexsero halved UK meningitis B cases in first year, says study

    provides reassurance to parents who have already vaccinated their children or wish to help protect their children from meningitis B in the future". ... Meningitis and septicaemia can kill in hours, and leave a substantial number of survivors with

More from news
Approximately 17 fully matching, plus 61 partially matching documents found.

Latest Intelligence

  • Re-awakening the emotion in healthcare communications Re-awakening the emotion in healthcare communications

    One example is the Teddy Bears’Picnic on the banks of the river Thames near Tower Bridge, which aimed to raise awareness of bacterial meningitis.

  • Pharma deals in June 2015 Pharma deals in June 2015

    When GSK acquired two additional rival meningitis vaccines from Novartis, namely Menveo and Bexsero, the European Commission and other antitrust regulators were concerned that this gave GSK too much power in ... As a result GSK has sold two of its own

  • Pharma deals during July 2014 Pharma deals during July 2014

    The transaction includes two vaccines currently marketed outside the US and primarily in Europe: NeisVac-C, a vaccine against group C meningococcal meningitis (MenC), and FSME-IMMUN against tick-borne encephalitis

  • Pharma deals during April 2014 Pharma deals during April 2014

    franchise. The icing on the cake is Bexsero for the prevention of meningitis B, which has EU approval and orphan drug designation in the US. ... Also included in the meningitis “ goodie bag” is the late-stage combo candidate MenABCWY.

  • Interview: Joseph Jimenez, Novartis Interview: Joseph Jimenez, Novartis

    The vaccines &diagnostics business is a leader in 'flu, and Novartis' emerging meningitis and pneumococcal franchises will continue to drive growth, Jimenez continues.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics